Animal models for the study of primary and secondary hypertension in humans

Biomedical Reports

Volumn 5, Issue 6, 2016, Pages 653-659

  Lin, Hiu Yu ^a   Lee, Yee Ting ^a   Chan, Yin Wah ^b   Tse, Gary ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Animal models; Endothelium; Hypertension; Mouse; Rat; Vascular function

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN; NITRIC OXIDE SYNTHASE; RENIN; VASOPRESSIN;

DIASTOLIC BLOOD PRESSURE; ENDOCRINE DISEASE; ENVIRONMENTAL STRESS; HUMAN; HYPERTENSION; INBREEDING; KIDNEY DISEASE; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; RENAL PARENCHYMAL HYPERTENSION; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 85011262610     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2016.784     Document Type: Review

References (119)

1. Chen R, Dharmarajan K, Kulkarni VT, Punnanithinont N, Gupta A, Bikdeli B, Mody PS and Ranasinghe I: Most important outcomes research papers on hypertension. Circ Cardiovasc Qual Outcomes 6: e26-e35, 2013.
2. Galosy RA, Clarke LK, Vasko MR and Crawford IL: Neurophysiology and neuropharmacology of cardiovascular regulation and stress. Neurosci Biobehav Rev 5: 137-175, 1981.
3. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 27: 481-490, 1996.
4. Sarikonda KV, Watson RE, Opara OC and Dipette DJ: Experimental animal models of hypertension. J Am Soc Hypertens 3: 158-165, 2009.
5. Lerman LO, Chade AR, Sica V and Napoli C: Animal models of hypertension: An overview. J Lab Clin Med 146: 160-173, 2005.
6. Tse G, Tse V and Yeo JM: Ventricular anti arrhythmic effects of heptanol in hypokalaemic, Langendorff perfused mouse hearts. Biomed Rep 4: 313-324, 2016.
7. Tse G, Tse V, Yeo JM and Sun B: Atrial anti arrhythmic effects of heptanol in Langendorff perfused mouse hearts. PLoS One 11: e0148858, 2016.
8. Tse G, Wong ST, Tse V and Yeo JM: Restitution analysis of alternans using dynamic pacing and its comparison with S1S2 restitution in heptanol treated, hypokalaemic Langendorff perfused mouse hearts. Biomed Rep 4: 673-680, 2016.
9. Tse G, Sun B, Wong ST, Tse V and Yeo JM: Ventricular anti arrhythmic effects of hypercalcaemia treatment in hyperka-laemic, Langendorff perfused mouse hearts. Biomed Rep 5: 301-310, 2016.
10. Tse G, Hothi SS, Grace AA and Huang CL: Ventricular arrhyth-mogenesis following slowed conduction in heptanol treated, Langendorff perfused mouse hearts. J Physiol Sci 62: 79-92, 2012.
11. Tse G and Yeo JM: Conduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctions. Int J Cardiol Heart Vasc 9: 75-82, 2015.
12. Tse G, Yeo JM, Tse V, Kwan SK and Sun B: Gap junction inhi-bition by heptanol increases ventricular arrhythmogenicity by decreasing conduction velocity without affecting repolarization properties or myocardial refractoriness in Langendorff perfused mouse hearts. Mol Med Rep (In press).
13. Leong XF, Ng CY and Jaarin K: Animal models in cardio-vascular research: Hypertension and atherosclerosis. BioMed Res Int 2015: 528757, 2015.
14. Doggrell SA and Brown L: Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39: 89-105, 1998.
15. Goldblatt H, Lynch J, Hanzal RF and Summerville WW: Studies on experimental: I. the production of persistent elevation of systolic blood pressure by means of renal ischenmia. J Exp Med 9: 347-379, 1934.
16. Gross DR: Animal models of hypertension. In: Animal models in cardiovascular research. Springer Netherlands, Dordrecht, pp 475-482, 1994.
17. Terris JM and Simmonds RC: The Yucatan miniature swine: An improved pig model for the study of desoxycorticosterone acetate (DOCA) and aldosterone hypertension. Proc Soc Exp Biol Med 171: 79-82, 1982.
18. Yagil Y and Yagil C: Genetic models of hypertension in experi-mental animals. Exp Nephrol 9: 1-9, 2001.
19. Twigger S, Lu J, Shimoyama M, Chen D, Pasko D, Long H, Ginster J, Chen CF, Nigam R, Kwitek A, etal: Rat Genome Database (RGD): Mapping disease onto the genome. Nucleic Acids Res 30: 125-128, 2002.
20. Trippodo NC and Frohlich ED: Similarities of genetic (spon-taneous) hypertension. Man and rat. Circ Res 48: 309-319, 1981.
21. Stoll M and Jacob HJ: Genetic rat models of hypertension: Relationship to human hypertension. Curr Hypertens Rep 3: 157-164, 2001.
22. Fuentes RM, Notkola IL, Shemeikka S, Tuomilehto J and NissinenA: Familial aggregation of blood pressure: A population based family study in eastern Finland. J Hum Hypertens 14: 441-445, 2000.
23. Perry IJ, Whincup PH and Shaper AG: Environmental factors in the development of essential hypertension. Br Med Bull 50: 246-259, 1994.
24. Williams SM, Haines JL and Moore JH: The use of animal models in the study of complex disease: All else is never equal or why do so many human studies fail to replicate animal findings? BioEssays 26: 170-179, 2004.
25. Fuster V, Lie JT, Badimon L, Rosemark JA, Badimon JJ and Bowie EJ: Spontaneous and diet induced coronary athero-sclerosis in normal swine and swine with von Willebrand disease. Arteriosclerosis 5: 67-73, 1985.
26. Fekete A, Rényi Vámos A and Szitás A: Experimental model of renovascular hypertension in dogs. Int Urol Nephrol 2: 391-400, 1970.
27. Hasiwa N, Bailey J, Clausing P, Daneshian M, Eileraas M, FarkasS, Gyertyán I, Hubrecht R, Kobel W, KrummenacherG, etal: Critical evaluation of the use of dogs in biomedical research and testing in Europe. ALTEX 28: 326-340, 2011.
28. Wiesel P, Mazzolai L, Nussberger J and Pedrazzini T: Two kidney, one clip and one kidney, one clip hypertension in mice. Hypertension 29: 1025-1030, 1997.
29. Okamura T, Miyazaki M, Inagami T and Toda N: Vascular renin angiotensin system in two kidney, one clip hypertensive rats. Hypertension 8: 560-565, 1986.
30. Yamasaki S: Divided renal and caval vein plasma renin activity in two kidney two clip hypertension in rabbits and variations of blood pressure, plasma volume and renal function following unilateral nephrectomy. J Urol 138: 1457-1460, 1987.
31. Sato K, Abe K, Seino M, Yasujima M, Imai Y, Sato M, HiwatariM, Omata K, Tanno M, Kohzuki M, etal: Renal vein plasma renin activity in patients with unilateral renovascular hypertension. Jpn Circ J 52: 431-436, 1988.
32. Sawamura T and Nakada T: Role of dopamine in the striatum, renin angiotensin system and renal sympathetic nerve on the development of two kidney, one clip Goldblatt hypertension. J Urol 155: 1108-1111, 1996.
33. Zeng J, Zhang Y, Mo J, Su Z and Huang R: Two kidney, two clip renovascular hypertensive rats can be used as stroke prone rats. Stroke 29: 1708-1713, 1998.
34. Murphy WR, Coleman TG, Smith TL and Stanek KA: Effects of graded renal artery constriction on blood pressure, renal artery pressure, and plasma renin activity in Goldblatt hypertension. Hypertension 6: 68-74, 1984.
35. Feldman L, Beberashvili I, Averbukh Z and Weissgarten J: Renal artery stenosis of solitary kidney: The dilemma. Ren Fail 26: 525-529, 2004.
36. Brunner HR, Kirshman JD, Sealey JE and Laragh JH: Hypertension of renal origin: Evidence for two different mech-anisms. Science 174: 1344-1346, 1971.
37. Preston RA and Epstein M: Renal parenchymal disease and hypertension. Semin Nephrol 15: 138-151, 1995.
38. van Koppen A, Verhaar MC, Bongartz LG and Joles JA: 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat. J Vis Exp 77: e50398, 2013.
39. Moore S and Mersereau WA: Microembolic renal ischemia, hypertension, and nephrosclerosis. Arch Pathol 85: 623-630, 1968.
40. Page IH: A method for producing persistent hypertension by cellophane. Science 89: 273-274, 1939.
41. Selye H, Hall CE and Rowley EM: Malignant hypertension produced by treatment with desoxycorticosterone acetate and sodium chloride. Can Med Assoc J 49: 88-92, 1943.
42. Iyer A, Chan V and Brown L: The DOCA salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress. Curr Cardiol Rev 6: 291-297, 2010.
43. Williams SK and Ogedegbe G: Unraveling the mechanism of renin angiotensin aldosterone system activation and target organ damage in hypertensive blacks. Hypertension 59: 10-11, 2012.
44. Wilson KM, Sumners C, Hathaway S and Fregly MJ: Mineralocorticoids modulate central angiotensin II receptors in rats. Brain Res 382: 87-96, 1986.
45. Möhring J, Möhring B, Petri M and Haack D: Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol 232: F260-F269, 1977.
46. Li L, Chu Y, Fink GD, Engelhardt JF, Heistad DD and ChenAF: Endothelin 1 stimulates arterial VCAM 1 expression via NADPH oxidase derived superoxide in mineralocorticoid hypertension. Hypertension 42: 997-1003, 2003.
47. Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, OhkitaM, Opgenorth TJ and Takaoka M: Different contributions of endothelin A and endothelin B receptors in the pathogenesis of deoxycorticosterone acetate salt induced hypertension in rats. Hypertension 33: 759-765, 1999.
48. Zambraski EJ, Ciccone CD and Izzo JL Jr: The role of the sympa-thetic nervous system in 2 kidney DOCA hypertensive Yucatan miniature swine. Clin Exp Hypertens A 8: 411-424, 1986.
49. Dahl LK, Knudsen KD, Heine M and Leitl G: Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats: Evidence for a humoral factor. J Exp Med 126: 687-699, 1967.
50. McCubbin JW, DeMoura RS, Page IH and Olmsted F: Arterial hypertension elicited by subpressor amounts of angiotensin. Science 149: 1394-1395, 1965.
51. Moncada S and Higgs A: The L arginine nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
52. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM and Zatz R: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
53. Lahera V, Salazar J, Salom MG and Romero JC: Deficient production of nitric oxide induces volume dependent hyper-tension. J Hypertens Suppl 10 (Suppl 7): S173-S177, 1992.
54. Zatz R and Baylis C: Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998.
55. Buñag RD, Takeda K and Riley E: Spontaneous remission of hypertension in awake rats chronically exposed to shaker stress. Hypertension 2: 311-318, 1980.
56. Smookler HH, Goebel KH, Siegel MI and Clarke DE: Hypertensive effects of prolonged auditory, visual, and motion stimulation. Fed Proc 32: 2105-2110, 1973.
57. McCann SM, Rothballer AB, Yeakel EH and Shenkin HA: Adrenalectomy and blood pressure of rats subjected to auditory stimulation. Am J Physiol 155: 128-131, 1948.
58. Kaufman LN, Peterson MM and Smith SM: Hypertension and sympathetic hyperactivity induced in rats by high fat or glucose diets. Am J Physiol 260: E95-E100, 1991.
59. Fregly MJ: Effects of Extremes of temperature on hypertensive rats. Am J Physiol 176: 275-281, 1954.
60. Papanek PE, Wood CE and Fregly MJ: Role of the sympathetic nervous system in cold induced hypertension in rats. J Appl Physiol (1985) 71: 300-306, 1991.
61. Donaldson GC, Robinson D and Allaway SL: An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin Sci (Lond) 92: 261-268, 1997.
62. Brennan PJ, Greenberg G, Miall WE and Thompson SG: Seasonal variation in arterial blood pressure. Br Med J (Clin Res Ed) 285: 919-923, 1982.
63. Coste SC, Qi Y, Brooks VL, McCarron DA and Hatton DC: Captopril and stress induced hypertension in the borderline hypertensive rat. J Hypertens 13: 1391-1398, 1995.
64. Hwang IS, Ho H, Hoffman BB and Reaven GM: Fructose induced insulin resistance and hypertension in rats. Hypertension 10: 512-516, 1987.
65. Garcia EA, Newhouse S, Caulfield MJ and Munroe PB: Genes and hypertension. Curr Pharm Des 9: 1679-1689, 2003.
66. Tabara Y, Kohara K and Miki T; Millennium Genome Project for Hypertension: Hunting for genes for hypertension: The millennium genome project for hypertension. Hypertens Res 35: 567-573, 2012.
67. Mann JF, Phillips MI, Dietz R, Haebara H and Ganten D: Effects of central and peripheral angiotensin blockade in hypertensive rats. Am J Physiol 234: H629-H637, 1978.
68. Yan L, Zhang JD, Wang B, Lv YJ, Jiang H, Liu GL, QiaoY, RenM and Guo XF: Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II induced H9C2 cells hypertrophy by enhancing PPAR γ expression and suppressing AP 1 activity. PLoS One 8: e72548, 2013.
69. Bagby SP, McDonald WJ and Mass RD: Serial renin angiotensin studies in spontaneously hypertensive and Wistar Kyoto normotensive rats. Transition from normal to high renin status during the established phase of spontaneous hypertension. Hypertension 1: 347-354, 1979.
70. Okamoto K and Aoki K: Development of a strain of sponta-neously hypertensive rats. Jpn Circ J 27: 282-293, 1963.
71. Kurtz TW and Morris RC Jr: Biological variability in Wistar Kyoto rats. Implications for research with the sponta-neously hypertensive rat. Hypertension 10: 127-131, 1987.
72. Tobian L, Lange JM, Ulm KM, Wold LJ and Iwai J: Potassium prevents death from strokes in hypertensive rats without lowering blood pressure. J Hypertens Suppl 2: S363-S366, 1984.
73. Mashimo T, Nabika T, Matsumoto C, Tamada T, Ueno K, Sawamura M, Ikeda K, Kato N, Nara Y and Yamori Y: Aging and salt loading modulate blood pressure QTLs in rats. Am J Hypertens 12: 1098-1104, 1999.
74. Smirk FH and Hall WH: Inherited hypertension in rats. Nature 182: 727-728, 1958.
75. Vincent M, Bornet H, Berthezene F, Dupont J and SassardJ: Thyroid function and blood pressure in two new strains of spontaneously hypertensive and normotensive rats. Clin Sci Mol Med 54: 391-395, 1978.
76. Vincent M, Gomez Sanchez CE, Bataillard A and Sassard J: Steroids during development of genetic hypertension in rats of Lyon strain. Am J Physiol 257: H506-H510, 1989.
77. Rapp JP and Dene H: Development and characteristics of inbred strains of Dahl salt sensitive and salt resistant rats. Hypertension 7: 340-349, 1985.
78. Dahl LK, Heine M and Tassinari L: Effects of chronic excess salt ingestion. Further demonstration that genetic factors influence the development of hypertension: Evidence from experimental hypertension due to cortisone and to adrenal regeneration. J Exp Med 122: 533-545, 1965.
79. Deng Y and Rapp JP: Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt sensitive rats. Nat Genet 1: 267-272, 1992.
80. Zamir N, Gutman Y and Ben Ishay D: Hypertension and brain catecholamine distribution in the Hebrew University Sabra, H and N rats. Clin Sci Mol Med Suppl 4: 105s 107s, 1978.
81. Kuijpers MH and Gruys E: Spontaneous hypertension and hyper-tensive renal disease in the fawn hooded rat. Br J Exp Pathol 65: 181-190, 1984.
82. Dobrian AD, Davies MJ, Prewitt RL and Lauterio TJ: Development of hypertension in a rat model of diet induced obesity. Hypertension 35: 1009-1015, 2000.
83. Mullins LJ, Bailey MA and Mullins JJ: Hypertension, kidney, and transgenics: A fresh perspective. Physiol Rev 86: 709-746, 2006.
84. Lagrange D and Fournié GJ: Generation of congenic and consomic rat strains. Methods Mol Biol 597: 243-266, 2010.
85. Cowley AW Jr, Liang M, Roman RJ, Greene AS and Jacob HJ: Consomic rat model systems for physiological genomics. Acta Physiol Scand 181: 585-592, 2004.
86. Mullins JJ, Peters J and Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren 2 gene. Nature 344: 541-544, 1990.
87. Montgomery HE, Kiernan LA, Whitworth CE, Fleming S, Unger T, Gohlke P, Mullins JJ and McEwan JR: Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens 16: 635-643, 1998.
88. Sigmund CD, Jones CA, Kane CM, Wu C, Lang JA and GrossKW: Regulated tissue and cell specific expression of the human renin gene in transgenic mice. Circ Res 70: 1070-1079, 1992.
89. Chung O, Schips T, Rohmeiss P, Gretz N, Strauch M and UngerT: Protein excretion and renal adaptation of transgenic mRen2 rats to changing oral sodium loads. J Hypertens Suppl 11: S188-S189, 1993.
90. Tse G: Novel conduction repolarization indices for the stratifi-cation of arrhythmic risk. J Geriatr Cardiol (In press).
91. Tse G: (Tpeak Tend)/QRS and (Tpeak Tend)/(QT x QRS): Novel markers for predicting arrhythmic risk in the Brugada syndrome. Europace (In press).
92. Tse G and Yan BP: Electrophysiological mechanisms of long and short QT syndromes: Insights from mouse models. IJC Heart & Vasculature (In press).
93. Tse G and Yan BP: Novel arrhythmic risk markers incorpo-rating QRS dispersion: QRSd × (Tpeak Tend)/QRS and QRSd×(Tpeak Tend)/(QT × QRS). Ann Noninvasive Electrocardiol Aug 18, 2016 (Epub ahead of print).
94. Tse G, Lai ET, Lee AP, Yan BP and Wong SH: Electrophysiological mechanisms of gastrointestinal arrhythmogenesis: Lessons from the heart. Front Physiol 7: 230, 2016.
95. Tse G, Wong ST, Tse V and Yeo JM: Variability in local action potential durations, dispersion of repolarization and wavelength restitution in aged wild type and Scn5a/-mouse hearts modelling human Brugada syndrome. J Geriatr Cardiol (Inpress).
96. Tse G: Mechanisms of cardiac arrhythmias. J Arrhythm 32: 75-81, 2016.
97. Tse G, Yeo JM, Chan YW, Lai ET and Yan BP: What is the arrhythmic substrate in viral myocarditis? Insights from clinical and animal studies. Front Physiol 7: 308, 2016.
98. Tse G and Yan BP: Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death. Europace (In press).
99. Sun B, Chen Z, Gu J, etal: The roles of tight and gap junctions in the pathogenesis of high fat diet induced atherosclerosis. Int J Clin Exp Pathol (In press).
100. Sun Z, Cade R, Zhang Z, Alouidor J and Van H: Angiotensinogen gene knockout delays and attenuates cold induced hypertension. Hypertension 41: 322-327, 2003.
101. Shesely EG, Maeda N, Kim H S, Desai KM, Krege JH, LaubachVE, Sherman PA, Sessa WC and Smithies O: Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93: 13176-13181, 1996.
102. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, YamagishiT, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, etal: Angiotensin II type 1a receptor deficient mice with hypotension and hyperreninemia. J Biol Chem 270: 18719-18722, 1995.
103. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, SpitzerA, Meinke G, Tsai FT, Sigler PB and Lifton RP: Activating miner-alocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289: 119-123, 2000.
104. Shimkets RA, Warnock DG, Bositis CM, Nelson Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, etal: Liddle’s syndrome: Heritable human hyper-tension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79: 407-414, 1994.
105. Tse G, Wong ST, Tse V, Lee YT, Lin HY and Yeo JM: Cardiac dynamics: Alternans and arrhythmogenesis. J Arrhythm (Inpress).
106. Tse G, Wong ST, Tse V and Yeo JM: Monophasic action potential recordings: Which is the recording electrode? J Basic Clin Physiol Pharmacol Apr 30, 2016 (Epub ahead of print).
107. Tse G, Lai ET, Yeo JM, Tse V and Wong SH: Mechanisms of electrical activation and conduction in the gastrointestinal system: Lessons from cardiac electrophysiology. Front Physiol 7: 182, 2016.
108. Tse G, Wong ST, Tse V and Yeo JM: Depolarization vs. repolar-ization: What is the mechanism of ventricular arrhythmogenesis underlying sodium channel haploinsufficiency in mouse hearts? Acta Physiol (Oxf) (In press).
109. Chen Z, Sun B, Tse G, Jiang J and Xu W: Reversibility of both sinus node dysfunction and reduced HCN4 mRNA expression level in an atrial tachycardia pacing model of tachycardia brady-cardia syndrome in rabbit hearts. Int J Clin Exp Pathol (In press).
110. Tse G, Lai ET, Tse V and Yeo JM: Molecular and electrophysi-ological mechanisms underlying cardiac arrhythmogenesis in diabetes mellitus. J Diabetes Res 2016: 1-8, 2016.
111. Tse G: Both transmural dispersion of repolarization and transmural dispersion of refractoriness are poor predictors of arrhythmogenicity: A role for the index of Cardiac Electrophysiological Balance (QT/QRS)? J Geriatr Cardiol (Inpress).
112. Tse G, Wong ST, Tse V and Yeo JM: Determination of action potential wavelength restitution in Scn5a/ mouse hearts modelling human Brugada syndrome. J Physiol (In press).
113. Choy L, Yeo JM, Tse V, Chan SP and Tse G: Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. Int J Cardiol Heart Vasc 12: 1-10, 2016.
114. Hu Z, Chen Z, Wang Y, etal: Effects of granulocyte colony stimulating factor on rabbit carotid and swine heart models of chronic obliterative arterial disease. Mol Med Rep (In press).
115. Tse G, Yan BP, Chan YW, Tian XY and Huang Y: Reactive oxygen species, endoplasmic reticulum stress and mitochondrial dysfunction: The link with cardiac arrhythmogenesis. Front Physiol 7: 313, 2016.
116. Tse G, Ali A, Prasad SK, Vassiliou V and Raphael CE: Atypical case of post partum cardiomyopathy: an overlap syndrome with arrhythmogenic right ventricular cardiomyopathy? BJR|case reports 1: 20150182, 2015.
117. Tse G, Ali A, Alpendurada F, Prasad S, Raphael CE and VassiliouV: Tuberculous constrictive pericarditis. Res Cardiovasc Med 4: e29614, 2015.
118. Vassiliou V, Chin C, Perperoglou A, Tse G, Ali A, Raphael C, Jabbour A, Newby D, Pennell D, Dweck M, etal: 93 ejection fraction by cardiovascular magnetic resonance predicts adverse outcomes post aortic valve replacement. Heart 100 (Suppl 3): A53-A54, 2014.
119. Hasenfuss G: Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39: 60-76, 1998.